TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3132524
log Bayes Factor = 57.2848
Chromosome 6   position 31,136,714  (GRCh37) Explore rs3132524 on Ensembl!
Variant rs3132524 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E11.9 Without complications
0.000 0.001 0.999
E83.1 Disorders of iron metabolism
0.999 0.001 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.001 0.999
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.007 0.993
E05.9 Thyrotoxicosis, unspecified
0.000 0.008 0.992
E78.0 Pure hypercholesterolaemia
0.000 0.016 0.984
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.020 0.980
G35 Multiple sclerosis
0.979 0.021 0.000
E70-E90 Metabolic disorders
0.000 0.024 0.976
L40 Psoriasis
0.000 0.033 0.967
E14 Unspecified diabetes mellitus
0.000 0.050 0.950
L40.5 Arthropathic psoriasis
0.000 0.081 0.919
E11.0 With coma
0.000 0.136 0.864
E78.8 Other disorders of lipoprotein metabolism
0.000 0.148 0.852
E10.3 With ophthalmic complications
0.000 0.149 0.851
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.151 0.849
E14.3 With ophthalmic complications
0.000 0.151 0.849
E07 Other disorders of thyroid
0.000 0.157 0.843
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.170 0.830
L40.0 Psoriasis vulgaris
0.000 0.177 0.823
E14.9 Without complications
0.000 0.178 0.822
L40.8 Other psoriasis
0.000 0.189 0.811
E78.2 Mixed hyperlipidaemia
0.000 0.190 0.810
E03.8 Other specified hypothyroidism
0.000 0.193 0.807
E11.1 With ketoacidosis
0.000 0.215 0.785
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.218 0.781
E79 Disorders of purine and pyrimidine metabolism
0.000 0.236 0.764
E74 Other disorders of carbohydrate metabolism
0.000 0.238 0.762
E78.1 Pure hyperglyceridaemia
0.000 0.243 0.757
E10.6 With other specified complications
0.000 0.244 0.756
E10.8 With unspecified complications
0.000 0.248 0.752
E14.5 With peripheral circulatory complications
0.000 0.250 0.750
E07.9 Disorder of thyroid, unspecified
0.000 0.258 0.742
E13 Other specified diabetes mellitus
0.000 0.259 0.741
L40.1 Generalised pustular psoriasis
0.000 0.261 0.739
K90 Intestinal malabsorption
0.000 0.273 0.727
E11.2 With renal complications
0.000 0.273 0.727
G35-G37 Demyelinating diseases of the central nervous system
0.722 0.278 0.000
E10.1 With ketoacidosis
0.000 0.281 0.719
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
E11.7 With multiple complications
0.000 0.284 0.716
E05.5 Thyroid crisis or storm
0.000 0.288 0.712
E05.4 Thyrotoxicosis factitia
0.000 0.288 0.712
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.288 0.712
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.288 0.712
E10.0 With coma
0.000 0.289 0.711
E40-E46 Malnutrition
0.000 0.290 0.710
E14.4 With neurological complications
0.000 0.291 0.709
E78.4 Other hyperlipidaemia
0.000 0.292 0.708
E78.6 Lipoprotein deficiency
0.000 0.295 0.705
E78.3 Hyperchylomicronaemia
0.000 0.297 0.703
E77 Disorders of glycoprotein metabolism
0.000 0.300 0.700
E76 Disorders of glycosaminoglycan metabolism
0.000 0.300 0.700
E72 Other disorders of amino-acid metabolism
0.000 0.300 0.700
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.300 0.700
E70 Disorders of aromatic amino-acid metabolism
0.000 0.300 0.700
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.300 0.700
L40.2 Acrodermatitis continua
0.000 0.307 0.693
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.309 0.691
L40.4 Guttate psoriasis
0.000 0.312 0.688
E14.6 With other specified complications
0.000 0.314 0.686
E14.1 With ketoacidosis
0.000 0.316 0.684
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.316 0.684
E14.7 With multiple complications
0.000 0.319 0.681
E14.0 With coma
0.000 0.319 0.681
E14.2 Withrenal complications
0.000 0.326 0.674
E84 Cystic fibrosis
0.000 0.326 0.674
E83 Disorders of mineral metabolism
0.639 0.327 0.034
E80.4 Gilbert's syndrome
0.000 0.334 0.666
G37 Other demyelinating diseases of central nervous system
0.658 0.342 0.000
E80.6 Other disorders of bilirubin metabolism
0.000 0.346 0.654
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.350 0.650
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.358 0.642
E14.8 With unspecified complications
0.000 0.359 0.641
E03.1 Congenital hypothyroidism without goitre
0.000 0.365 0.634
E80.2 Other porphyria
0.000 0.366 0.634
E11.8 With unspecified complications
0.000 0.371 0.628
E16 Other disorders of pancreatic internal secretion
0.000 0.375 0.625
E10.2 With renal complications
0.000 0.380 0.619
E78.5 Hyperlipidaemia, unspecified
0.000 0.387 0.613
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.388 0.612
E10.5 With peripheral circulatory complications
0.000 0.389 0.611
E07.1 Dyshormogenetic goitre
0.000 0.395 0.605
E07.0 Hypersecretion of calcitonin
0.000 0.395 0.605
L40-L45 Papulosquamous disorders
0.000 0.397 0.603
G37.9 Demyelinating disease of central nervous system, unspecified
0.599 0.401 0.000
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.405 0.595
E80.5 Crigler-Najjar syndrome
0.000 0.405 0.595
E80.3 Defects of catalase and peroxydase
0.000 0.405 0.595
E80.0 Hereditary erythropoietic porphyria
0.000 0.405 0.595
E05.8 Other thyrotoxicosis
0.000 0.408 0.592
E80.1 Porphyria cutanea tarda
0.000 0.410 0.590
C83.3 Large cell (diffuse)
0.000 0.417 0.583
K90.9 Intestinal malabsorption, unspecified
0.000 0.417 0.583
E88 Other metabolic disorders
0.000 0.418 0.582
E07.8 Other specified disorders of thyroid
0.000 0.421 0.579
E13.9 Without complications
0.000 0.423 0.577
L40.3 Pustulosis palmaris et plantaris
0.000 0.431 0.569
E73 Lactose intolerance
0.000 0.433 0.567
E15 Nondiabetic hypoglycaemic coma
0.000 0.440 0.560
E83.3 Disorders of phosphorus metabolism
0.549 0.441 0.010
G36 Other acute disseminated demyelination
0.554 0.446 0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.452 0.548
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.452 0.548
E79.1 Lesch-Nyhan syndrome
0.000 0.452 0.548
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.454 0.546
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.454 0.546
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.454 0.546
E74.2 Disorders of galactose metabolism
0.000 0.454 0.546
E74.1 Disorders of fructose metabolism
0.000 0.454 0.546
E13.8 With unspecified complications
0.000 0.468 0.532
E13.7 With multiple complications
0.000 0.468 0.532
E13.6 With other specified complications
0.000 0.468 0.532
E13.5 With peripheral circulatory complications
0.000 0.468 0.532
E13.4 With neurological complications
0.000 0.468 0.532
E13.2 With renal complications
0.000 0.468 0.532
E13.1 With ketoacidosis
0.000 0.468 0.532
E13.0 With coma
0.000 0.468 0.532
G37.8 Other specified demyelinating diseases of central nervous system
0.529 0.471 0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.473 0.527
E11.5 With peripheral circulatory complications
0.000 0.478 0.522
K90.3 Pancreatic steatorrhoea
0.000 0.478 0.521
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.478 0.521
K90.1 Tropical sprue
0.000 0.478 0.521
E83.9 Disorder of mineral metabolism, unspecified
0.495 0.483 0.022
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.484 0.516
E10.4 With neurological complications
0.000 0.484 0.516
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
M06.9 Rheumatoid arthritis, unspecified
0.000 0.486 0.514
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.491 0.509
E45 Retarded development following protein-energy malnutrition
0.000 0.491 0.509
E43 Unspecified severe protein-energy malnutrition
0.000 0.491 0.509
E42 Marasmic kwashiorkor
0.000 0.491 0.509
E41 Nutritional marasmus
0.000 0.491 0.509
E40 Kwashiorkor
0.000 0.491 0.509
L43 Lichen planus
0.000 0.492 0.508
E13.3 With ophthalmic complications
0.000 0.495 0.505
E46 Unspecified protein-energy malnutrition
0.000 0.498 0.502
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.498 0.502
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.498 0.502
E70.3 Albinism
0.000 0.498 0.502
E70.2 Disorders of tyrosine metabolism
0.000 0.498 0.502
E70.1 Other hyperphenylalaninaemias
0.000 0.498 0.502
E70.0 Classical phenylketonuria
0.000 0.498 0.502
E71.3 Disorders of fatty-acid metabolism
0.000 0.498 0.502
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.498 0.502
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.498 0.502
E71.0 Maple-syrup-urine disease
0.000 0.498 0.502
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.498 0.502
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.498 0.502
E72.5 Disorders of glycine metabolism
0.000 0.498 0.502
E72.4 Disorders of ornithine metabolism
0.000 0.498 0.502
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.498 0.502
E72.2 Disorders of urea cycle metabolism
0.000 0.498 0.502
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.498 0.502
E72.0 Disorders of amino-acid transport
0.000 0.498 0.502
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.498 0.502
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.498 0.502
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.498 0.502
E76.2 Other mucopolysaccharidoses
0.000 0.498 0.502
E76.1 Mucopolysaccharidosis, type II
0.000 0.498 0.502
E76.0 Mucopolysaccharidosis, type I
0.000 0.498 0.502
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.498 0.502
E77.8 Other disorders of glycoprotein metabolism
0.000 0.498 0.502
E77.1 Defects in glycoprotein degradation
0.000 0.498 0.502
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.498 0.502
K90.8 Other intestinal malabsorption
0.000 0.499 0.501
E75.6 Lipid storage disorder, unspecified
0.000 0.509 0.490
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.509 0.490
E75.3 Sphingolipidosis, unspecified
0.000 0.509 0.490
E75.2 Other sphingolipidosis
0.000 0.509 0.490
E75.1 Other gangliosidosis
0.000 0.509 0.490
E75.0 GM2 gangliosidosis
0.000 0.509 0.490
E16.2 Hypoglycaemia, unspecified
0.000 0.511 0.489
E16.1 Other hypoglycaemia
0.000 0.511 0.489
E74.0 Glycogen storage disease
0.000 0.514 0.486
E11.6 With other specified complications
0.000 0.516 0.483
E84.8 Cystic fibrosis with other manifestations
0.000 0.516 0.483
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.516 0.483
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.516 0.483
E83.8 Other disorders of mineral metabolism
0.458 0.517 0.025
E83.2 Disorders of zinc metabolism
0.458 0.517 0.025
E83.0 Disorders of copper metabolism
0.458 0.517 0.025
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.519 0.481
E75.5 Other lipid storage disorders
0.000 0.525 0.475
G37.5 Concentric sclerosis [Balo]
0.472 0.528 0.000
G37.4 Subacute necrotising myelitis
0.472 0.528 0.000
G37.2 Central pontine myelinolysis
0.472 0.528 0.000
G37.1 Central demyelination of corpus callosum
0.472 0.528 0.000
G37.0 Diffuse sclerosis
0.472 0.528 0.000
L42 Pityriasis rosea
0.000 0.528 0.471
L43.9 Lichen planus, unspecified
0.000 0.537 0.463
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.538 0.462
E84.9 Cystic fibrosis, unspecified
0.000 0.542 0.458
E88.2 Lipomatosis, not elsewhere classified
0.000 0.544 0.455
C83 Diffuse non-Hodgkin's lymphoma
0.005 0.548 0.447
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.548 0.452
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.001 0.551 0.448
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.448 0.552 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.552 0.448
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.552 0.448
E16.4 Abnormal secretion of gastrin
0.000 0.552 0.448
E16.3 Increased secretion of glucagon
0.000 0.552 0.448
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.558 0.442
C85.1 B-cell lymphoma, unspecified
0.000 0.559 0.441
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.007 0.560 0.433
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.561 0.439
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.564 0.436
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.565 0.435
G36.0 Neuromyelitis optica [Devic]
0.433 0.567 0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.567 0.433
L44 Other papulosquamous disorders
0.000 0.567 0.433
L41 Parapsoriasis
0.000 0.567 0.433
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.567 0.433
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.568 0.432
E11.4 With neurological complications
0.000 0.569 0.431
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.002 0.573 0.425
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.001 0.576 0.423
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.579 0.421
E88.9 Metabolic disorder, unspecified
0.000 0.583 0.417
E88.8 Other specified metabolic disorders
0.000 0.583 0.417
E88.3 Tumour lysis syndrome
0.000 0.587 0.412
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.590 0.410
E73.8 Other lactose intolerance
0.000 0.593 0.406
E73.1 Secondary lactase deficiency
0.000 0.593 0.406
E73.0 Congenital lactase deficiency
0.000 0.593 0.406
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.596 0.404
E89.4 Postprocedural ovarian failure
0.000 0.598 0.401
E85 Amyloidosis
0.001 0.600 0.400
G36.9 Acute disseminated demyelination, unspecified
0.397 0.603 0.000
G36.8 Other specified acute disseminated demyelination
0.397 0.603 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.397 0.603 0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.613 0.386
E06 Thyroiditis
0.000 0.618 0.382
E20-E35 Disorders of other endocrine glands
0.000 0.618 0.382
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.622 0.378
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.622 0.378
E89.5 Postprocedural testicular hypofunction
0.000 0.622 0.378
E89.1 Postprocedural hypoinsulinaemia
0.000 0.622 0.378
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.633 0.366
E44.1 Mild protein-energy malnutrition
0.000 0.635 0.365
E44.0 Moderate protein-energy malnutrition
0.000 0.635 0.365
E89.3 Postprocedural hypopituitarism
0.000 0.635 0.365
L43.3 Subacute (active) lichen planus
0.000 0.636 0.364
L43.2 Lichenoid drug reaction
0.000 0.636 0.364
L43.1 Bullous lichen planus
0.000 0.636 0.364
L43.0 Hypertrophic lichen planus
0.000 0.636 0.364
E83.4 Disorders of magnesium metabolism
0.342 0.645 0.012
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.648 0.352
C83.7 Burkitt's tumour
0.003 0.651 0.346
C82.2 Large cell, follicular
0.001 0.655 0.344
E28 Ovarian dysfunction
0.000 0.662 0.338
E65-E68 Obesity and other hyperalimentation
0.000 0.665 0.335
C82.3 Follicular lymphoma grade IIIa
0.001 0.669 0.330
C81 Hodgkin's disease
0.004 0.674 0.323
C83.6 Undifferentiated (diffuse)
0.004 0.676 0.321
C83.5 Lymphoblastic (diffuse)
0.004 0.676 0.321
C83.4 Immunoblastic (diffuse)
0.004 0.676 0.321
C83.2 Mixed small and large cell (diffuse)
0.004 0.676 0.321
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.001 0.678 0.321
C85.0 Lymphosarcoma
0.001 0.678 0.321
E89.2 Postprocedural hypoparathyroidism
0.000 0.679 0.321
E28.2 Polycystic ovarian syndrome
0.000 0.681 0.319
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.005 0.684 0.311
C86 Other specified types of T/NK-cell lymphoma
0.005 0.684 0.311
C84 Peripheral and cutaneous T-cell lymphomas
0.004 0.685 0.311
C85.7 Other specified types of non-Hodgkin's lymphoma
0.001 0.687 0.313
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.687 0.313
L41.9 Parapsoriasis, unspecified
0.000 0.689 0.310
L41.8 Other parapsoriasis
0.000 0.689 0.310
L41.5 Retiform parapsoriasis
0.000 0.689 0.310
L41.4 Large plaque parapsoriasis
0.000 0.689 0.310
L41.3 Small plaque parapsoriasis
0.000 0.689 0.310
L41.2 Lymphomatoid papulosis
0.000 0.689 0.310
L41.1 Pityriasis lichenoides chronica
0.000 0.689 0.310
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.689 0.310
L44.9 Papulosquamous disorder, unspecified
0.000 0.689 0.310
L44.8 Other specified papulosquamous disorders
0.000 0.689 0.310
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.689 0.310
L44.3 Lichen ruber moniliformis
0.000 0.689 0.310
L44.2 Lichen striatus
0.000 0.689 0.310
L44.1 Lichen nitidus
0.000 0.689 0.310
L44.0 Pityriasis rubra pilaris
0.000 0.689 0.310
E24 Cushing's syndrome
0.000 0.692 0.308
E23 Hypofunction and other disorders of pituitary gland
0.000 0.693 0.307
C82.6 Cutaneous follicle centre lymphoma
0.002 0.694 0.305
C82.5 Diffuse follicle centre lymphoma
0.002 0.694 0.305
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.001 0.694 0.305
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.003 0.699 0.297
E83.5 Disorders of calcium metabolism
0.293 0.703 0.004
C82.0 Small cleaved cell, follicular
0.001 0.707 0.291
L43.8 Other lichen planus
0.000 0.708 0.291
C94 Other leukaemias of specified cell type
0.005 0.711 0.284
E85.2 Heredofamilial amyloidosis, unspecified
0.001 0.713 0.287
E85.1 Neuropathic heredofamilial amyloidosis
0.001 0.713 0.287
E85.0 Nonneuropathic heredofamilial amyloidosis
0.001 0.713 0.287
E21.3 Hyperparathyroidism, unspecified
0.000 0.713 0.287
C82.4 Follicular lymphoma grade IIIb
0.002 0.716 0.283
C81.9 Hodgkin's disease, unspecified
0.001 0.721 0.278
E06.5 Other chronic thyroiditis
0.000 0.726 0.274
E06.4 Drug-induced thyroiditis
0.000 0.726 0.274
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.726 0.274
E06.0 Acute thyroiditis
0.000 0.726 0.274
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.726 0.274
E32 Diseases of thymus
0.000 0.726 0.274
E31 Polyglandular dysfunction
0.000 0.726 0.274
E30 Disorders of puberty, not elsewhere classified
0.000 0.726 0.274
E25 Adrenogenital disorders
0.000 0.726 0.274
E73.9 Lactose intolerance, unspecified
0.001 0.726 0.273
E85.8 Other amyloidosis
0.001 0.727 0.272
C93 Monocytic leukaemia
0.006 0.731 0.264
E06.1 Subacute thyroiditis
0.001 0.739 0.261
C83.1 Small cleaved cell (diffuse)
0.004 0.740 0.257
E85.9 Amyloidosis, unspecified
0.001 0.742 0.257
E50-E64 Other nutritional deficiencies
0.000 0.743 0.256
E23.7 Disorder of pituitary gland, unspecified
0.000 0.749 0.251
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.750 0.250
C88 Malignant immunoproliferative diseases
0.006 0.751 0.243
E24.2 Drug-induced Cushing's syndrome
0.000 0.753 0.247
E23.2 Diabetes insipidus
0.000 0.756 0.244
E26 Hyperaldosteronism
0.000 0.756 0.244
E28.9 Ovarian dysfunction, unspecified
0.000 0.757 0.243
E28.8 Other ovarian dysfunction
0.000 0.757 0.243
E28.1 Androgen excess
0.000 0.757 0.243
E28.0 Oestrogen excess
0.000 0.757 0.243
C91 Lymphoid leukaemia
0.004 0.759 0.237
E67 Other hyperalimentation
0.000 0.759 0.240
E68 Sequelae of hyperalimentation
0.000 0.759 0.240
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.761 0.239
C84.5 Other and unspecified T-cell lymphomas
0.002 0.765 0.232
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.003 0.766 0.231
C81.3 Lymphocytic depletion
0.003 0.766 0.231
C81.2 Mixed cellularity
0.003 0.766 0.231
E24.9 Cushing's syndrome, unspecified
0.000 0.766 0.234
E20 Hypoparathyroidism
0.000 0.766 0.233
E85.4 Organ-limited amyloidosis
0.001 0.767 0.232
C81.7 Other Hodgkin's disease
0.003 0.768 0.229
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.769 0.230
M06 Other rheumatoid arthritis
0.000 0.771 0.229
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.004 0.773 0.223
C86.5 Angioimmunoblastic T-cell lymphoma
0.004 0.773 0.223
C86.4 Blastic NK-cell lymphoma
0.004 0.773 0.223
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.004 0.773 0.223
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.004 0.773 0.223
C86.1 Hepatosplenic T-cell lymphoma
0.004 0.773 0.223
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.004 0.773 0.223
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.004 0.773 0.223
C96.8 Histiocytic sarcoma
0.004 0.773 0.223
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.004 0.773 0.223
C96.6 Unifocal Langerhans-cell histiocytosis
0.004 0.773 0.223
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.004 0.773 0.223
C96.4 Sarcoma of dendritic cells (accessory cells)
0.004 0.773 0.223
C96.3 True histiocytic lymphoma
0.004 0.773 0.223
C96.2 Malignant mast cell tumour
0.004 0.773 0.223
C96.1 Malignant histiocytosis
0.004 0.773 0.223
C96.0 Letterer-Siwe disease
0.004 0.773 0.223
C84.0 Mycosis fungoides
0.003 0.774 0.224
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.774 0.226
C84.9 Mature T/NK-cell lymphoma, unspecified
0.003 0.774 0.223
C84.8 Cutaneous T-cell lymphoma, unspecified
0.003 0.774 0.223
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.003 0.774 0.223
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.003 0.774 0.223
C84.3 Lymphoepithelioid lymphoma
0.003 0.774 0.223
C84.2 T-zone lymphoma
0.003 0.774 0.223
C84.1 Sezary's diease
0.003 0.774 0.223
C81.0 Lymphocytic predominance
0.003 0.774 0.223
E21.4 Other specified disorders of parathyroid gland
0.000 0.776 0.224
E21.2 Other hyperparathyroidism
0.000 0.776 0.224
E11.3 With ophthalmic complications
0.000 0.779 0.221
E24.8 Other Cushing's syndrome
0.000 0.779 0.221
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.779 0.221
E24.3 Ectopic ACTH syndrome
0.000 0.779 0.221
E24.1 Nelson's syndrome
0.000 0.779 0.221
E24.0 Pituitary-dependent Cushing's disease
0.000 0.779 0.221
C82.1 Mixed small cleaved and large cell, follicular
0.002 0.779 0.219
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.779 0.220
E23.1 Drug-induced hypopituitarism
0.000 0.779 0.220
C91.9 Lymphoid leukaemia, unspecified
0.002 0.785 0.213
C84.4 Peripheral T-cell lymphoma
0.003 0.786 0.212
E23.6 Other disorders of pituitary gland
0.000 0.786 0.214
C95 Leukaemia of unspecified cell type
0.006 0.789 0.204
C94.7 Other specified leukaemias
0.004 0.792 0.204
C94.5 Acute myelofibrosis
0.004 0.792 0.204
C94.4 Acute panmyelosis
0.004 0.792 0.204
C94.3 Mast cell leukaemia
0.004 0.792 0.204
C94.2 Acute megakaryoblastic leukaemia
0.004 0.792 0.204
C94.1 Chronic erythraemia
0.004 0.792 0.204
C94.0 Acute erythraemia and erythroleukaemia
0.004 0.792 0.204
E29 Testicular dysfunction
0.000 0.794 0.206
E23.0 Hypopituitarism
0.000 0.796 0.204
E85.3 Secondary systemic amyloidosis
0.001 0.796 0.203
E25.9 Adrenogenital disorder, unspecified
0.000 0.803 0.196
E25.8 Other adrenogenital disorders
0.000 0.803 0.196
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.803 0.196
E30.9 Disorder of puberty, unspecified
0.000 0.803 0.196
E30.8 Other disorders of puberty
0.000 0.803 0.196
E30.1 Precocious puberty
0.000 0.803 0.196
E30.0 Delayed puberty
0.000 0.803 0.196
E31.9 Polyglandular dysfunction, unspecified
0.000 0.803 0.196
E31.8 Other polyglandular dysfunction
0.000 0.803 0.196
E31.1 Polyglandular hyperfunction
0.000 0.803 0.196
E31.0 Autoimmune polyglandular failure
0.000 0.803 0.196
E32.9 Disease of thymus, unspecified
0.000 0.803 0.196
E32.8 Other diseases of thymus
0.000 0.803 0.196
E32.1 Abscess of thymus
0.000 0.803 0.196
E32.0 Persistent hyperplasia of thymus
0.000 0.803 0.196
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.803 0.196
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.803 0.196
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.803 0.196
M06.3 Rheumatoid nodule
0.000 0.804 0.196
K91.4 Colostomy and enterostomy malfunction
0.194 0.806 0.000
C93.9 Monocytic leukaemia, unspecified
0.004 0.807 0.189
C93.7 Other monocytic leukaemia
0.004 0.807 0.189
C93.3 Juvenile myelomonocytic leukaemia
0.004 0.807 0.189
C93.2 Subacute monocytic leukaemia
0.004 0.807 0.189
C93.0 Acute monocytic leukaemia
0.004 0.807 0.189
E28.3 Primary ovarian failure
0.000 0.811 0.188
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.816 0.184
E63 Other nutritional deficiencies
0.000 0.816 0.184
E50 Vitamin A deficiency
0.000 0.816 0.184
E60 Dietary zinc deficiency
0.000 0.816 0.184
E59 Dietary selenium deficiency
0.000 0.816 0.184
E54 Ascorbic acid deficiency
0.000 0.816 0.184
E52 Niacin deficiency [pellagra]
0.000 0.816 0.184
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.004 0.818 0.178
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.004 0.818 0.178
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.004 0.819 0.177
C83.0 Small cell (diffuse)
0.004 0.819 0.176
E56 Other vitamin deficiencies
0.000 0.820 0.180
C81.1 Nodular sclerosis
0.003 0.820 0.177
E06.3 Autoimmune thyroiditis
0.000 0.821 0.179
C88.9 Malignant immunoproliferative disease, unspecified
0.004 0.821 0.175
C88.7 Other malignant immunoproliferative diseases
0.004 0.821 0.175
C88.3 Immunoproliferative small intestinal disease
0.004 0.821 0.175
C88.2 Gamma heavy chain disease
0.004 0.821 0.175
C88.1 Alpha heavy chain disease
0.004 0.821 0.175
E58 Dietary calcium deficiency
0.000 0.822 0.178
E65 Localised adiposity
0.000 0.823 0.177
E26.9 Hyperaldosteronism, unspecified
0.000 0.825 0.175
E26.8 Other hyperaldosteronism
0.000 0.825 0.175
E26.1 Secondary hyperaldosteronism
0.000 0.825 0.175
C91.5 Adult T-cell leukaemia
0.003 0.826 0.171
C91.8 Mature B-cell leukaemia Burkitt-type
0.003 0.827 0.170
C91.7 Other lymphoid leukaemia
0.003 0.827 0.170
C91.6 Prolymphocytic leukaemia of T-cell type
0.003 0.827 0.170
C91.3 Prolymphocytic leukaemia
0.003 0.827 0.170
C91.2 Subacute lymphocytic leukaemia
0.003 0.827 0.170
E67.8 Other specified hyperalimentation
0.000 0.827 0.172
E67.3 Hypervitaminosis D
0.000 0.827 0.172
E67.2 Megavitamin-B6 syndrome
0.000 0.827 0.172
E67.1 Hypercarotenaemia
0.000 0.827 0.172
E67.0 Hypervitaminosis A
0.000 0.827 0.172
E06.9 Thyroiditis, unspecified
0.001 0.827 0.172
E22 Hyperfunction of pituitary gland
0.000 0.829 0.171
E51 Thiamine deficiency
0.000 0.830 0.170
E20.8 Other hypoparathyroidism
0.000 0.832 0.167
E20.1 Pseudohypoparathyroidism
0.000 0.832 0.167
E20.0 Idiopathic hypoparathyroidism
0.000 0.832 0.167
M06.4 Inflammatory polyarthropathy
0.000 0.835 0.165
M06.2 Rheumatoid bursitis
0.000 0.836 0.164
M06.1 Adult-onset Still's disease
0.000 0.836 0.164
M06.34 Rheumatoid nodule (Hand)
0.000 0.836 0.164
M06.32 Rheumatoid nodule (Upper arm)
0.000 0.836 0.164
C92 Myeloid leukaemia
0.006 0.838 0.157
M06.8 Other specified rheumatoid arthritis
0.000 0.839 0.161
E61 Deficiency of other nutrient elements
0.000 0.839 0.161
C91.0 Acute lymphoblastic leukaemia
0.003 0.845 0.152

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.